|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT01771029 |
|
Date of registration:
|
09/01/2013 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Technical Evaluation of Brahms PCT Direct
|
|
Scientific title:
|
Technical Evaluation of a Whole Blood Rapid Test Measuring Procalcitonin (BRAHMS PCT Direct) |
|
Date of first enrolment:
|
February 2013 |
|
Target sample size:
|
150 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01771029 |
|
Study type:
|
Observational [Patient Registry] |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
|
Germany
|
Switzerland
| | | | | |
|
Contacts
|
|
Name:
|
Philipp Schuetz, PD, Dr.med. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Kantonsspital Aarau |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Age > 18 years
- possible infection at initial presentation
- informed consent
Exclusion Criteria:
- none
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Infection
|
|
Primary Outcome(s)
|
|
Correlation between BRAHMS PCT direct and reference method.
[Time Frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks]
|
|
Secondary Outcome(s)
|
|
Time to result
[Time Frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|